Agfa HealthCare has signed a multi-million dollar deal with Thomas Memorial Hospital in South Charleston, WV and will ...
The FDA has granted approval to Cook Inc. for its new 36mm Zenith FLEX AAA Endovascular Graft for the treatment of ...
British researchers have concluded that counseling and education aimed at preventing coronary heart disease have no impact on mortality and little effect in terms of clinical events, reports “heartwire.” Dr Shah Ebrahim (London School of Tropical Medicine, UK) and colleagues report their findings in the Oct. 18, 2006 Cochrane Database of Systematic Reviews.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Early clinical results from Abbott's ongoing ABSORB clinical trial, the world's first study to evaluate the safety and performance of a fully bioabsorbable drug-eluting stent platform for the treatment of coronary artery disease in humans, were presented during the 18th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.
Cardium Therapeutics and its subsidiary InnerCool Therapies reported on preclinical data demonstrating a new and ...
ev3 Inc. has announced a worldwide fracture-free guarantee in support of its new EverFlex family of stents. In the event ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
GlaxoSmithKline and Flamel Technologies announced FDA approval of once-a-day Coreg CR (carvedilol phosphate) extended ...
Boston Scientific Corporation announced that an independent meta-analysis of more than 3,500 patients from five clinical ...
A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested by scientists. The first human experiment with the dissolving stent is being conducted with 26 patients at hospitals in New Zealand and Europe, the Associated Press reported. The study is designed to test whether the stent is safe enough to be used in larger studies.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
A new program designed to provide hospitals with practical tools to help them reduce door-to-balloon times in STEMI ...
Radiofrequency ablation is more effective than treatment with amiodarone for the prevention of atrial flutter recurrence in patients who experienced a first symptomatic episode, according to the results of a new study. In addition to the superiority of ablation over amiodarone, there was no increased risk of atrial fibrillation, even in this cohort of older patients, report investigators.
CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to percutaneously implant its proprietary porcine pericardial-tissue bioprosthesis over the severely calcified aortic heart valve of an 89-year-old woman.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by French doctors including Jean-Louis Mas, M.D., of the Hospitaux Sainte-Anne in Paris.
Obesity and the illnesses associated with it cost the U.S. some 90.7 billion dollars a year in health care costs, a University of Pennsylvania researcher said. Among developed countries, the U.S. has the most obese and overweight people, representing 66 percent of its overall population.
Boston Scientific has European CE clearance to begin marketing a private-label XIENCE V everolimus-eluting coronary ...